12:00 AM
Dec 23, 2013
 |  BC Week In Review  |  Company News  |  Deals

Circuit Therapeutics, Boehringer Ingelheim deal

Circuit and Boehringer partnered to use Circuit's optogenetics technology to screen for compounds against jointly selected targets for psychiatric disorders. The...

Read the full 81 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >